BDBM264092 4-(4-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)piperazin-1-yl)phenyl)morpholin-3-one::US9714232, 5

SMILES Fc1ccc2[nH]cc(CCCCN3CCN(CC3)c3ccc(cc3)N3CCOCC3=O)c2c1

InChI Key InChIKey=UVXGOLGGZUOLPH-UHFFFAOYSA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 264092   

Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM264092(4-(4-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)piperazin...)
Affinity DataKi:  3.10nMpH: 7.4Assay Description:Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-0H-DPAT (Perkin-Elmer) in the absence o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM264092(4-(4-(4-(4-(5-fluoro-1H-indol-3-yl)butyl)piperazin...)
Affinity DataIC50:  6.30nMpH: 7.4Assay Description:The synaptosomes (150 μg) prepared from a rat brain were incubated at 37° C. for 15 minutes with 0.1 μCi [3H]5-HT in the absence or presenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent